In a Series A round led by Peak XV Partners, medical coding platform Arintra has raised $21 million. Other strategic investors include Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and others.
Key Highlights
- Arintra secures $21M in Series A funding led by Peak XV to scale healthcare AI platform.
- Funds will fuel product innovation, expand into US health systems, and support launch of Bay Area HQ.
The funds will be utilized to increase adoption among physician groups and U.S. health systems, speed up product development, grow the company's workforce, and establish a new Bay Area headquarters.
Healthcare providers can use Arintra's GenAI-native autonomous medical coding platform, which was founded in 2020 by Nitesh Shroff and Preeti Bhargava. Its system combines clinical documentation improvement (CDI) and denials prevention into a single platform, automating the conversion of clinical documentation into precise insurance codes.
In addition to cutting expenses, increasing claim accuracy, and speeding up cash flow, the business model aims to enable providers to obtain complete, compliant reimbursement. In order to function within current workflows, Arintra integrates with EHR systems such as Epic and Athena using an enterprise SaaS model.
Also Read: Elever Secures $1.1 Mn in Pre-Series A Funding Led by Brand Capital
"Healthcare reimbursement is essentially flawed. Shroff, the CEO of Arintra, stated, "Autonomous coding hasn't kept up with payers' rapid changes, which use technology and policy to shift more burden onto providers." "We created Arintra to relieve the strain on frontline teams and assist healthcare providers in securing compliant revenue at scale."
With its revenue assurance approach, the company offers a quantifiable return on investment to major health systems, hospitals, and physician groups.
